| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd7cdd54fdc16358767b3fb60dd14289 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2093
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate |
2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0414b277ca97e3ac563f4321e4200397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c702e2fddf346559230a5b3971f26b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb20ec475fc83de1e2eace3e9a1b7f42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893d38c6c8e8bdf463d0287840cfb11b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a7ec46e8da775c1818bd9d883f56732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a40202179a6482765d9e9af1d4be327f |
| publicationDate |
2007-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007212372-A1 |
| titleOfInvention |
Methods for the treatment and prophylaxis of demeyelinating disease |
| abstract |
The present invention relates to a method for the treatment and/or prophylaxis of a nervous system disease, demyelinating disease and/or an inflammatory disease of either the central or peripheral nervous system such as but not limited to an encephalopathic condition and even more particularly an encephalomyelopathic condition. The present invention further provides the use of leukemia inhibitory factor or derivatives, homologues or analogues thereof in the treatment and/or prophylaxis of a nervous system disease, demyelinating disease and/or an inflammatory disease of either the central or peripheral nervous system. Leukemia inhibitory factor may be used alone or in combination with one or more other therapeutic molecules. |
| priorityDate |
2000-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |